Estimation of Problematic Drug Use in Spain - Examples of estimation based in surveys- Data and thought
|
|
- June Harrington
- 5 years ago
- Views:
Transcription
1 Prevalence and patterns of drug use among general population. GPS Indicator. Annual Expert Meeting June EMCDDA (Lisbon) Estimation of Problematic Drug Use in Spain - Examples of estimation based in surveys- Data and thought Spanish Observatory on Drugs Julia Gonzalez Rosario Sendino Noelia Llorens Begoña Brime Aurora Ruiz Elena Alvarez (speaker)
2 Problematic Drug Use INTRODUCTION Concept and aspects to take into account Source of information and methods, in Spain EXAMPLES Cocaine PDU estimation based in surveys (frequency & age/vulnerability) Objective. Methods. Results. Cannabis PDU base in surveys (scales). Objective. Methods. Results. DISCUSSION Utility of surveys to estimate PDU, combination of different methods
3 Population Drug users Problematic users Approach of of problematic users... The drug use is is causing, the users (or (or others), negative physical, psychological or or social consequences or or hightrisk of of having them. EMCDDA Until 2012: problem drug use is injecting drug use or regular and/or long-term use of opiates, cocaine and/or amphetamines 2013: focuses on high-risk drug use. Drug use that is causing actual harm (negative consequences) to the person (including dependence but also other health, psychological or social problem) or is placing the person at a high probability/risk of suffering such harms
4 Population Drug users Problematic users It is useful to identified problematic user to orienteand implement policies (prevention, treatment, social needs, harm reduction, economics and human resources). Focus in target population. How many? It is possibleto estimate the number and some characteristics of problematic users. Profile? It is necessary define criteria, based in evidences, consensus and practical issues, in order to improve the comparability. Multidisciplinary work.
5 Type of drug alcohol, cocaine, cannabis, heroine prevalence Users characteristic Health situation, previous pathologies, pregnancy, age Some aspects to take into account Consequences for users or others Physic, psychological, social.. Pattern of use Frequency, chronicity, route of administration intensity, (how much -gr./hour), poliproblematics Accidents, infections, mental diseases SOURCES OF INFORMATION:available information or new indicators. Surveys (general population, specific group ) treatment centers, traffic offenses, judicial system, mortality, emergencies facilities, social services, infectious diseases registries, etc. METHODS: Direct or indirect estimations surveys, scales, combinated methods Standardization of definitions, methodologies and analysis comparability
6 1) SURVEYS General pop. Survey (15-64 y.o) Student survey (14-18 y.o) Others: Prison, specific population... Information sources in Spain Strengths of periodic surveys: Periodic and long series: biennale from Big sample: 20,000 a 30,000 Complete questionnaire (50 min): basic + special modules. International comparability. 2) DRUG INDICATORS Hospital emergencies Drug Mortality Treatment Demand indicator infectious diseases Problem drug use annual since (2011) Annual since (2010) Annual since (2011) Annual since 1986 Annual since ) EXTERNAL SOURCES. Supply indicators, etc.
7 Main Methods for PDU estimates in Spain ,6 73,6 40,2 32,4 Last year prevalence. Spain 2010/ ,6 26,4 EDADES (15-64 a.) 2011 General population survey 2011(15-64 y.o) Student survey (14-18 y.o) ESTUDES (14-18 a) ,2 2,6 0,7 1,7 0,6 1,6 0,4 2,1 0,10,6 Alcohol Tabaco Cannabis Cocaína Éxtasis Anfetaminas Alucinógenos Heroína Alcohol AUDIT scale. General Population Survey Cannabis PDU scales (CAST. SDS. DSM-IV. M-CIDI) Students surveys Cocaine Direct estimation (frequency and age). General Population surveys y Heroine Indirect estimation. Multiplier method GPS & TDI From 2006 to Source: Spanish Observatory on Drugs
8 INTRODUCTION. OBJETIVE. METHOD.. RESULTS. DISCUSSION. OBJETIVE Estimation of cocaine problematic drug users in Spain, using general population survey, based in frequency and age (vulnerability) METHOD Source of information General population survey y.o. National coverage. Face to face questionnaire. 22, 128 questionnaires. Criteria No clear consensus, no evidence based criteria 1) Frequency based How many times in a period of time (month/year) do a person consume?. Person (15-64 y.o.) who used cocaine 30 days or more within the last 12 months OR who used cocaine 10 days or more within the last 30 days 2) Frequency & age (vulnerability) 20 years old?? Phisic/psycic/socialvulnerability. Implement prevention in early ages. Persons (15-20 y.o) who used cocaine 10 d or more within the last 12 month AND who used cocaine from 1 to 3 d within in the last 30 days PLUS persons (21 to 64 y.o.) who used cocaine 30 days or more within the last 12 months OR who used cocaine 10 d or more within the last 30 days.(more than 20 y.o)
9 COCAINE PROBLEMATIC DRUG USE, SPAIN 2011 Using GPS: frequency (frequency + age) Population (15-64 y.o.).) Cocaine users Problematic users Life time: 8.8% n= Last year: 2.2% n= Last month: 1.1% n= ( ) Can be considerer cocaine PDU IN Spain in 2011: 0.39% (0.41%) of population y.o. 4.5% (4.7%) of (15-64 y.o.) life time prevalence users 17.0% (17.9%) of (15-64 y.o.) last year prevalence users 35.6% (37.5%) of (15-64 y.o. last month prevalence users Source: Spanish Observatory on Drugs
10 PREVALENCE VS PROBLEMATIC DRUG USE % Problematic drug use (%). Spain 2009 & Based in frequency & age in GPS (15-64 y.o) , ,7 17,9 15,0 31,2 37,4 Continuity Among people ever using cocaine: 1 out of 4 consumed last year 1 out of 7 consumed last month. 0 CP alg. vez CP Ult. año CP Ult. mes PU life time PU last year PU last month Cocaine prevalence (%) in general population (15-64 y.o). Spain Cocaine prevalence (%) in student (14-18 y.o) Spain Life alguna timevez Last último year año Last último mont mes 8 Prevalence results by them 6 self doesn't 4 show a complete picture Source: Spanish Observatory on Drugs
11 Cross indicator analysis. COCAINE DRD cocaine with or without any other susbstances (nº) Nº Nº defunciones death Hospital emergency detected cocaine (nº) Nº Nº urgencias hospital emergencies hosp se detecta when cocaína cocaine is detected Seizures (kg/10) Incautaciones (Kg/10) Nº cocaine first treatment Nº primeros First treatments tratamiento for cocaine por cocaína (nº) % Last consumo last month último prevalence mes (%) y.o. años (%) y.o. Last Last month prevaelnce prevalence (%) y.o. (%) y.o. % consumo último mes años.. 4 3,5 3 2, , , Source: Spanish Observatory on Drugs
12 INTRODUCTION. OBJETIVE. METHOD.. RESULTS. DISCUSSION. OBJETIVES Psychometric evaluation of scales. European project on course. Estimation of cannabis problematic drug use (14-18 y.o). Spain, METHOD Year Scale CAST SDS DSM-IV CAST CAST SDS M-CIDI CAST N survey 26,454 30,183 31,967 26,000 N CAST (valid questionnaires last year) Source of information 3,569 7,173 6,303 In process Student survey y.o National coverage. self-administered questionnaires (45 min.) CAST-Cannabis Abuse Screening Test. 6 items. Measure social & healthconsequences for user and others. SDS-Severity of Dependence Scale. 5 items. Measure dependence. DSM-IV-American Psychiatric Association. 5 items for abuse and 13 for dependence. DSM-IV criteria. M-CIDI-Munich Composite International Diagnostic Interview.
13 CANNABIS PROBLEMATIC DRUD USERS (CAST) SPAIN, Population ( y.o.).) Cannabis last year users Problematic drug user (26.4% of total population) Problematic users. 15.3% among last year users. 4.6% among total population. Source: Spanish Observatory on Drugs
14 CANNABIS PDU TRENDS (CAST), SPAIN 2006, 2008, 2010 CAST results. Percentage of non problematic/low/high risk among cannabis last year users (14-18 y.o). 100% 80% 60% 40% 20% 13,3 14,3 15,3 20,7 18,6 19,9 66,0 67,1 64,8 Increase trends in cannabis problematic drug use in teenagers. 0% no No problemático problematic bajo Low riesgo risk alto High riesgo risk Year % of cannabis high risk users among population y.o Nº of cannabis high risk users among population y.o 73, , ,340
15 Cannabis prevalence(14-18 y.o). Spain Number of cannabis treatment demands. Spain, First treatment Life time Alguna vez en la vida Últimos Last year 12 meses Últimos Last mont 30 días Previous treatments % hospital emergenciesrelated to drug when cannabis is present. Spain Treatment episodes in< 18 years (%) different drugs. Spain, Source: Spanish Observatory on Drugs
16 Some thought based in our experience different scenarios dif. answers dif. methods. Conceptual definition depend of situation, drug, user characteristic, pattern of use. Look for a complete pictureusing multiples sources and different indicators. Available information. Triangulation of the information. Problematic use!! Look for right sources & methods. Are survey a good methods for estimate problematic use? Surveys can't answer everything but yes many things Part of the puzzle to understand drug use? First step to oriented specific studies?. Methods : -General population/specific population. -Scales (AUDIT, CAST, DSM-V ). -Frequency of use, age, others. -Surveys + other indicator. Some limitation: classics surveys limitations. Drug with low prevalence. Survey with small sample. High risk-social stigma. Out of sampling frame Surveys are a possible tool: -Available(more cost effective than create new indicator). -Robust(quality and trends). -Flexible(periodic modules, adapt to needs).
17 PDU concept Population Drug users PDU It is useful It is possible Continue working in define criteria, methods and source of information SURVEYS POSSIBLE TOOL Spanish Observatory on Drugs.
PDU (Problem drug use) revision summary
European Monitoring Centre for Drugs and Drug Addiction PDU (Problem drug use) revision summary 20 February 2013 Danica Thanki and Julián Vicente Introduction This document is a summary of the concepts
More informationTrends in cannabis use and cannabis-related treatment demand in Switzerland
Trends in cannabis use and cannabis-related treatment demand in Switzerland Etienne Maffli, Addiction Switzerland, Lausanne TDI and HRDU annual expert meetings, Lisbon, sept. 23-26 2014 Data sources available
More informationSTATISTICAL BULLETIN 2016
STATISTICAL BULLETIN Title: STATISTICAL BULLETIN Author: General-Directorate for Intervention on Addictive Behaviours and Dependencies (SICAD) / Monitoring and Information Directorate (DMI) / Statistics
More informationSTATISTICAL BULLETIN 2015
STATISTICAL BULLETIN Title: Author: General-Directorate for Intervention on Addictive Behaviours and Dependencies (SICAD) / Monitoring and Information Directorate (DMI) / Statistics and Research Division
More informationEstimating Cannabis Use disorder
Estimating Cannabis Use disorder Institut für Therapieforschung München by using measures of heavy use over time Elena Gomes de Matos 1) & Ludwig Kraus 1,2) 1) IFT Institut für Therapieforschung, Munich,
More informationStatistics on Drug Misuse: England, 2007
Statistics on Drug Misuse: England, 2007 Summary For the first time, this annual statistical bulletin presents information on drug misuse among both adults and children. The topics covered include: Prevalence
More informationPerspectives for information on alcohol use in the EU
EMCDDA Perspectives for information on alcohol use in the EU Julian Vicente Luxembourg 20-21 March 2018 CNAPA meeting Topics in this presentation ESPAD project (now with EMCDDA) in students Alcohol ( Tobacco
More informationNew patterns of drug use in Hungary
New patterns of drug use in Hungary Gergely Horváth Hungarian National Focal Point PDU Annual Expert Meeting 2012 Lisbon, 25-26 September 2012 First glance From 2009 on decrease in heroin availability,
More informationTrends in injecting drug use in Europe
Trends in injecting drug use in Europe Linda Montanari, Bruno Guarita and Danica Thanki Annual Expert Meeting on Drug-Related Infectious Diseases Lisbon, 15-17 October Overview of the presentation 1) Information
More informationNEW TRENDS IN USE, CONSEQUENCES / DAMAGES AND MARKETS. 2nd Annual Meeting of National Drug Observatories COPOLAD II Lisbon, November 2017
NEW TRENDS IN USE, CONSEQUENCES / DAMAGES AND MARKETS 2nd Annual Meeting of National Drug Observatories COPOLAD II Lisbon, 13-17 November 217 THE QUESTIONS In the last two years What recent changes and
More informationThe italian interactive system for addiction data management
The italian interactive system for addiction data management High risk drug use and drug treatment in Europe 2014 Bruno Genetti Lisbon 24-26 September 2014 Rationale Italian legislation governing drugs
More informationThe drugs situation in Ireland: an overview of trends from 2005 to 2015.
The drugs situation in Ireland: an overview of trends from 2005 to 2015. July 2017 Geoff Bates Centre for Public Health at Liverpool John Moores University Contents Contents... 1 List of acronyms... 3
More informationTaking Stock of the 2009 PoA Research and Trend Analysis Branch
Taking Stock of the 2009 PoA Research and Trend Analysis Branch Eliminate or reduce significantly and measurably: The five targets Illicit cultivation of opium, coca, cannabis Illicit demand of drugs and
More informationRepublic of Turkey- Ministry of Interior-Turkish National Police- Counter Narcotics Department Date of submission: Contact person:
In the UNGASS outcome document, Member States reiterated their commitment to supporting efforts at all levels, based on the common and shared responsibility, to effectively address and counter the world
More informationPERSPECTIVES ON DRUGS Emergency health consequences of cocaine use in Europe
UPDATED 16. 5. 2014 PERSPECTIVES ON DRUGS Emergency health consequences of cocaine use in Europe Every year, several thousands of cocainerelated emergencies are reported in Europe, along with hundreds
More informationINTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D
INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FIFTY-FIFTH REGULAR SESSION April 29 - May 1, 2014 Washington, D.C. OEA/Ser.L/XIV.2.55 CICAD/doc.2089/14
More informationImproving our capacity of identification and reporting on emerging trends. New methods and new areas of analysis
Improving our capacity of identification and reporting on emerging trends New methods and new areas of analysis Monitoring challenges Rapidly changing, globalised drug market Growth of online and virtual
More informationAnnual report 2009: the state of the drugs problem in Europe
Annual report 2009: the state of the drugs problem in Europe Alessandro Pirona, Rome 05/11/2009 European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Established: 1993 Seat: Lisbon Staff: 100
More informationTDI 3.0 implementation. TDI Prevalence. Linda Montanari, Bruno Guarita
TDI 3.0 implementation TDI Prevalence Linda Montanari, Bruno Guarita Lisbon, 21 22 September 2015 Workshop 3.0 The role and value of data from drug treatment services (TDI working group) TDI implementation
More informationProject Meeting Prague
Project Meeting Prague IO1 Assessment 9.11.217 CHRISTINA PADBERG ON BEHALF OF FRANKFURT UAS Current Status Assessment matrix was fully evaluated Experts have been interviewed, Interviews were fully evaluated
More informationPsychometric properties of the RAPS4 in Argentina, Mexico and United States.
Psychometric properties of the RAPS4 in Argentina, Mexico and United States. Mariana Cremonte UMDP CONICET Mar del Plata, Argentina Rubén Ledesma UNMDP CONICET Mar del Plata, Argentina Cheryl Cherpitel
More informationJoão Goulão, MD. EVIDENCE-BASED POLICIES 21 April April João Goulão
INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security DRUGS SUMMIT EUROPEAN, LATIN AMERICAN AND CARIBBEAN MAYORS AND CITIES April 21 23, 2010 Lugo, Spain OEA/Ser.L/XIV.4.1
More informationDesign of studies to evaluate and validate scales and indicators of problematic drug use. Report on advances in Activity 1.
Design of studies to evaluate and validate scales and indicators of problematic drug use Report on advances in Activity 1.4 COPOLAD General objective To procuce necessary methodological designs for National
More informationHarms and harm reduction workbook. Country X
Harms and harm reduction workbook Country X 1 Table of Contents T0. Summary... 3 T1. National profile... 3 T1.1 Drug-related deaths... 3 T1.2 Drug related acute emergencies... 4 T1.3 Drug related infectious
More informationInjection of new psychoactive drugs in Romania multi-indicator analysis
Injection of new psychoactive drugs in Romania multi-indicator analysis Psycho-Sociologist Lavinus Sava - RNAA LISBON 26-27 October 2013 Romania, 2012 2012 stabilization of drug phenomenon in Romania,
More informationStatistics on Drug Misuse: England, 2008
Statistics on Drug Misuse: England, 2008 Summary This annual statistical report presents information on drug misuse among both adults and children. It includes a focus on young adults. The topics covered
More informationHIV/AIDS Think Tank meeting: EMCDDA report. Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015
HIV/AIDS Think Tank meeting: EMCDDA report Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015 European Drug Report 2015 Drop o Trends in seizures by substance from 2009 o Drug and related long-term
More informationPublic drug policies Catalonia
Public drug policies Catalonia Public Health Agency of Catalonia Xavier Majó Roca Catalonia Barcelona Territory: 32.000 km2 Population: 7.523.000 M Own language and culture 1. What s happened in Catalonia
More informationSolving the ecstasy puzzle case study in the Netherlands
Solving the ecstasy puzzle case study in the Netherlands Margriet van Laar Head of Drug Monitoring department & Netherlands Focal Point Meeting on 20 years EMCDDA Key Indicators Ecstasy Many studies show
More informationOverview of drug-induced deaths in Europe - What does the data tell us?
Overview of drug-induced deaths in Europe - What does the data tell us? João Matias, Isabelle Giraudon, Julián Vicente EMCDDA expert group on the key-indicator Drug-related deaths and mortality among drug
More informationEMCDDA-update HIV/HCV among people who inject drugs: situation and response
EMCDDA-update HIV/HCV among people who inject drugs: situation and response Dagmar Hedrich EU Think Tank HIV/AIDS: 24-25 November 2015, Luxembourg Latest European overview Multi-indicator based analysis
More informationRapporteur report of Session 2: New Trends in TDI clients. Thursday, September 20th 2012, ( Room 106) Chair: Dragica Katalinic
Rapporteur report of Session 2: New Trends in TDI clients Thursday, September 20th 2012, (14.30 16.00 Room 106) Chair: Dragica Katalinic Rapporteur: Christine Marchand-Agius 1. Presentation on new trends
More informationA review of drug-related deaths in seven Northern European countries
A review of drug-related deaths in seven Northern European countries Tim Millar a & Andy McAuley b a) Division of Psychology & Mental Health, School of Health Sciences, The University of Manchester b)
More informationSubstance misuse among young people The data for
Substance misuse among young people The data for 28-9 EFFECTIVE TREATMENT CHANGING LIVES www.nta.nhs.uk Substance misuse among young people The data for 28-9 More teenagers are receiving help for drug
More informationresearch on addic ORMING PDU REVISION: ELIMINARY RESULTS OF LITERATURE
research on addic ORMING PDU REVISION: ELIMINARY RESULTS OF LITERATURE VIEW oject content ect CT.12.EPI.0.046.1.0 to assist the EMCDDA in e aspects of the process of Problem drug use key icator revision
More informationThe issues facing Europe
The issues facing Europe An overview Andrew Cunningham Supply reduction and New Drugs unit 28 May 2015 European Drug Report 2015 https://youtu.be/vzzyp3k6psk 2 Opiates (heroin) Europe s main drug issue
More informationWorld Drug Report 2018 Methodology Report. Research and Trend Analysis Branch UNODC, Vienna
World Drug Report 2018 Methodology Report Research and Trend Analysis Branch UNODC, Vienna Table of Contents 1. Introduction... 1 Sources of information... 1 2. Data on drug use and health consequences
More information12/13/2016. Gender-sensitive prevention and treatment services for alcohol and drug users in Belgium. 6 What about What we know
Gender-sensitive prevention and treatment services for alcohol and drug users in Belgium Julie Schamp Wouter Vanderplasschen 2 What about What we know Who we are What we aim to do What we plan to do Preliminary
More informationViewpoints on future dissemination of take-home naloxone: opportunities and challenges
Viewpoints on future dissemination of take-home naloxone: opportunities and challenges Dagmar Hedrich & Isabelle Giraudon, EMCDDA Bergen, 1 September 2015 OVERDOSEKONFERANSEN 2015 ThINCBergen2015: The
More informationScottish Blues- Benzodiazepines and Drug Related Deaths in Scotland
Scottish Blues- Benzodiazepines and Drug Related Deaths in Scotland EMCDDA Sep. 25 th 2014 Dr Saket Priyadarshi Associate Medical Director NHS Greater Glasgow and Clyde Vice-Chair, National Forum on Drug
More informationPresented at: Annual expert meeting on Drug-related deaths (DRD) and Drug-Related infectious diseases (DRDI), October 2014, EMCDDA, Lisbon
Assessing the gender effect in mortality risk and excess mortality from natural and external causes among heroin and cocaine users in Spain Does being heroin or cocaine user add a differential risk of
More informationCombination of various data bases and estimation methods to better estimate the market from the demand and the supply side and consequences
EU project JUST/2010/DPIP/AG/1410: New methodological tools for policy and programme evaluation, www.drugpolicyevaluation.eu Combination of various data bases and estimation methods to better estimate
More informationThe epidemiology of HIV infection in Greece HIV/AIDS reporting system
HIV outbreak in IDUsin Greece Update on situation and responses Anastasios Fotiou, REITOX Focal Point-Greece Foteini Giannou, Office of HIV and STIs, Hellenic Centre for Disease Control and Prevention
More information4. Problem drug use Introduction
4. Problem drug use 4.1. Introduction Problem use: general context A set of studies and work has been conducted in recent years to establish a new estimate of the number of problematic drug users in France.
More informationDRUG USE LEVELS IN FRANCE IN 2010
DRUG USE LEVELS IN FRANCE IN 2010 First results from the Health Barometer survey (OFDT /INPES analysis) OFDT 3 avenue du Stade de France 93218 Saint-Denis La Plaine cedex Tel : 01 41 62 77 16 Fax : 01
More information1 Cannabis problems in context: understanding increasing in treatment demand
1 Cannabis problems in context: understanding increasing in treatment demand 1.1 Demand for treatment for cannabis use 1.1.1 Proportion of clients with primary cannabis problems Cannabis can be found as
More informationProf. Dr Heino Stöver Faculty of Health and Social Work University of Applied Sciences Frankfurt, Germany
Prof. Dr Heino Stöver Faculty of Health and Social Work University of Applied Sciences Frankfurt, Germany The Treatment Demand Indicator (TDI) 12th Annual Expert Meeting 2012 Lisbon (EMCDDA), Portugal
More informationProfessor Paul I Dargan
General Overview of the Euro-DEN Dataset: 5529 presentations with acute drug toxicity in 16 sentinel European centres Professor Paul I Dargan Guy s s and St Thomas NHS Foundation Trust and King s s College
More informationDrug consumption among roma population
NATIONAL ANTIDRUG AGENCY Drug consumption among roma population High risk drug use and drug treatment in Europe 2014 Special populations and drug problems Lisbon, 24 September 2014 General characteristics
More informationDrug Misuse Research Division
Drug Misuse Research Division contents Occasional Paper No. 1/ 2002 - Background - NDTRS methodology - Treatment as an indicator of drug misuse - Treatment provision - Extent of the problem - Socio-demographic
More informationStatistics on Drug Misuse: England, 2012
Statistics on Drug Misuse: England, 2012 Copyright 2012, The Health and Social Care Information Centre. All Rights Reserved. Copyright 2012, The Health and Social Care Information Centre. All Rights Reserved.
More informationCannabis trends in France TDI data
Cannabis trends in France TDI data Tanja Bastianić High risk drug use and drug treatment in Europe 2014 Lisbon, September 2014 Cannabis in general population in France 2 2 Cannabis in France Cannabis is
More informationEstimating cannabis consumption in seven EU countries by differentiating different user groups
Improving Mental Health by Sharing Knowledge Estimating cannabis consumption in seven EU countries by differentiating different user groups Margriet van Laar 1, Tom Frijns 1, Franz Trautmann 1, Linda Lombi
More informationPart of the Continuum of Care. Harm Reduction. Gino Vumbaca President Harm Reduction Australia
Part of the Continuum of Care Harm Reduction Gino Vumbaca President Harm Reduction Australia What is Harm Reduction The defining features are the focus on the reduction of harm, rather than on the prevention
More informationResearch Methodology. Introduction 10/18/2016. Introduction. User name: cp6691 Password: stats.
Research Methodology 1 http://spectrum.troy.edu/drsmall/ Web Page User name: cp6691 Password: stats 2 Pieces of the Puzzle Chapter 2 Literature Review Chapter 1 Chapter 3 Methodology No Data Collection
More informationLegal and institutional framework of combating drugs abuse in the. Republic of Croatia
Government of the Republic of Croatia Legal and institutional framework of combating drugs abuse in the Republic of Croatia 9th EXASS Net meeting Zagreb, 11-12 October 2012 Content of the presentation
More informationThe Netherlands Drug Situation Summary
The Netherlands Drug Situation 2010 - Summary Developments in drug law and policies (chapter 1) The intended new Dutch drug policy was delayed because the Dutch government fell in February 2010. The resigned
More informationORGANIZATION OF AMERICAN STATES
ORGANIZATION OF AMERICAN STATES INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION FIRST INTER-REGIONAL FORUM OF EU-LAC CITIES: PUBLIC POLICIES IN DRUG TREATMENT April 2 5, 2008 Santo Domingo, Dominican Republic
More information2014 NATIONAL REPORT (2013 data) TO THE EMCDDA by the Reitox National Focal Point. SPAIN New Development, Trends. Reitox
2014 NATIONAL REPORT (2013 data) TO THE EMCDDA by the Reitox National Focal Point SPAIN New Development, Trends Reitox INDEX SUMMARY 5 1. DRUG POLICY: LEGISLATION, STRATEGIES AND ECONOMIC ANALYSIS 13
More informationNEEDLE AND SYRINGE PROGRAMMES MONITORING IN LITHUANIA
NEEDLE AND SYRINGE PROGRAMMES MONITORING IN LITHUANIA Dr. Audronė Astrauskienė Drug control department under the Government of the Republic of Lithuania 2010 10 25 Harm reduction services development in
More informationConsumption of new substances with psychoactive effects (NSPE)
Consumption of new substances with psychoactive effects (NSPE) Aurora LEFTER, sociologist Bogdan GHEORGHE, MD LISBON 20-21 SEPTEMBER 2012 Survey Risks Assessment of the use of new psychoactive substances
More informationEconomic and Social Council
United Nations E/CN.3/2014/19 Economic and Social Council Distr.: General 9 December 2013 Original: English Statistical Commission Forty-fifth session 4-7 March 2014 Item 4 (d) of the provisional agenda*
More informationMarijuana in Washington, DC. Arrests, Usage, and Related Data
Marijuana in Washington, DC Arrests, Usage, and Related Data Jon Gettman, Ph.D. The Bulletin of Cannabis Reform www.drugscience.org November 5, 2009 1 Introduction This state report is part of a comprehensive
More informationMost recent data, analyses and feed-back from the 2016 DRID national updates
Most recent data, analyses and feed-back from the 216 DRID national updates Eleni Kalamara, Dagmar Hedrich, Linda Montanari, Isabelle Giraudon 15-16 June 217, Lisbon DRID/TDI annual expert meeting DRID
More informationWorkshop summary. Exchange on data collection challenges related to new psychoactive substances use. Presentation of the situation
Workshop summary Presentation of the situation Among countries participating in the workshop the level and characteristics of NPSs use showed great diversity. The use and the problem use of NPSs is a major
More informationThe Global S.M.A.R.T. Programme: Synthetics Monitoring: Analysis, Reporting and Trends. ATS trends, programme progress and planned expansion
The Global S.M.A.R.T. Programme: Synthetics Monitoring: Analysis, Reporting and Trends ATS trends, programme progress and planned expansion Regional SMART Workshop, Bangkok, 5-6 August 2010 Beate Hammond,
More information1. Background 2. The Big Picture 3. Global trends 4. Regional trends E/SE Asia 5. Effective responses
Simultaneous launches: Vienna and Bangkok 13 Sep 2011 1. Background 2. The Big Picture 3. Global trends 4. Regional trends E/SE Asia 5. Effective responses The international drug control system 1. Based
More informationQUESTIONNAIRE. Submission Information. Information for follow-up purposes. Head of International Drug Policy, Home Office
IMPLEMENTATION OF THE RECOMMENDATIONS ADOPTED BY THE TWENTY-SIXTH SESSION OF HONLEA, LATIN AMERICA AND THE CARIBBEAN, SANTIAGO, CHILE 3-7 OCTOBER 2016 QUESTIONNAIRE Submission Information Name of country:
More informationRecent trends in drug problems and service provision in Greece
Recent trends in drug problems and service provision in Greece Anastasios Fotiou Epidemiology Unit The Greek Reitox focal point of the EMCDDA at the Understanding the dynamics, nature and scale of drug
More informationNATIONAL DRUG INFORMATION NETWORK
REGIONAL WORKSHOP ON DRUG INFORMATION NETWORKS (DINs) BERMUDA S NATIONAL DRUG INFORMATION NETWORK Antigua & Barbuda August 1, 2012 Dr. Kyla Raynor, Senior Research Officer/Policy Analyst Where did the
More informationDMRI Drug Misuse Research Initiative
DMRI Drug Misuse Research Initiative Executive Summary Comorbidity in the national psychiatric morbidity surveys Research Report submitted to the Department of Health in February 2004 Report prepared by:
More informationAcute Drug Toxicity Data
Acute Drug Toxicity Data Recreational drug use is common Systematic data is available on: Prevalence of drug use Drug seizures Use of treatment agencies for problem drug use Drug-related fatalities There
More informationJSNA Substance Misuse
JSNA Substance Misuse Introduction 9.1. Substance misuse causes less damage to health in absolute population terms than tobacco or alcohol. However, its association with crime and antisocial behaviour
More informationNeurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP
Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP Disclosures This speaker has no conflicts of interest to disclose Objectives Define drug abuse and addiction Identify the
More informationEvidence table for systematic reviews
Evidence table for systematic reviews Topic: CB use and dependence Reviewer: CMF Abbreviations: y- years Reference Research Parameters Population Outcomes Funding Additional comments Bibliographic reference
More informationMethodology World Drug Report 2017
Methodology World Drug Report 2017 Considerable efforts have been made over the years to improve the estimates presented in the World Drug Report, which rely, to a large extent, on information submitted
More informationPOLICY, LEGISLATION, ECONOMIC ANALYSIS AND MEDIA COVERAGE. Last data available Indicator (sphere)
POLICY, LEGISLATION, ECONOMIC ANALYSIS AND MEDIA COVERAGE Amendments in laws and legal regulations number 8 2 NDC Expenditures for activities against drugs and drug addictions in Bulgaria [1] BGN 1 102
More informationPsychosis with coexisting substance misuse
Psychosis with coexisting substance misuse Clinical case scenarios for primary, secondary and third sector services Implementing NICE guidance March 2011 OTC α blocker information sheet for GP s (2010)
More informationSPAIN New Development, Trends and In-depth Information on Selected Issues
2013 NATIONAL REPORT (2012 data) FOR THE EMCDDA by the Reitox National Focal Point SPAIN New Development, Trends and In-depth Information on Selected Issues REITOX INDEX Summary (major developments, highlights,
More informationBROMLEY JOINT STRATEGIC NEEDS ASSESSMENT Substance misuse is the harmful use of substances (such as drugs and alcohol) for non-medical purposes.
13. Substance Misuse Introduction Substance misuse is the harmful use of substances (such as drugs and alcohol) for non-medical purposes. The term substance misuse often refers to illegal drugs, but, some
More informationDRUG COURTS Study Day in Brussels 23 October 2015
DRUG COURTS Study Day in Brussels 23 October 2015 The Portuguese Experience João Goulão General-Director for Intervention on Addictive Behaviors and Dependencies National Coordinator on Drugs, Drug Addiction
More informationMethodology World Drug Report 2010
Methodology World Drug Report 2010 Considerable efforts have been made over the years to improve the estimates presented in this report. Nonetheless, challenges remain in making such estimates because
More informationMethodology. Sources and limitations of data on the supply side
Considerable efforts have been made over the last few years to improve the estimates presented in this report. Nonetheless, the data must still be interpreted with caution because of the clandestine nature
More informationLITERATURE REVIEW: BULGARIA
Directorate-General Justice, Freedom and Security LITERATURE REVIEW: BULGARIA THROUGHCARE WORKING IN PARTNERSHIP 1 CONTENTS 1.Drug use 3 1.1 Trends and statistics 3 1.2 Drug use amongst specific groups
More informationEMCDDA looks behind rising numbers of young people in cannabis treatment
2004 ANNUAL REPORT: SELECTED ISSUES EMCDDA looks behind rising numbers of young people in cannabis treatment (25.11.2004 LISBON EMBARGO 10H00 CET/Brussels time) Specialised drug treatment centres in many
More informationDrug using mothers: retaining care of their children
Drug using mothers: factors associated with retaining care of their children Gail Gilchrist 1 and Avril Taylor 2 1 L'Institut Municipal d'investigació Mèdica, Barcelona, Spain p g,, p 2 University of the
More informationHIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications
HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications Don Des Jarlais, Ph.D. Professor of Psychiatry, Icahn School of Medicine at Mount Sinai UNODC 2014
More informationDrug information systems: Principles, structures and indicators **
FOR PARTICIPANTS ONLY E/CN.7/2000/CRP.3 3 March 2000 ORIGINAL: ENGLISH COMMISSION ON NARCOTIC DRUGS Forty-third session Vienna, 6-15 March 2000 Item 4(a) and (b) of the provisional agenda* Reduction of
More informationReferences to Argentina Part 1 RECENT STATISTICS AND TREND ANALYSIS OF ILLICIT DRUG MARKETS
References to Argentina Part 1 RECENT STATISTICS AND TREND ANALYSIS OF ILLICIT DRUG MARKETS A. EXTENT OF ILLICIT DRUG USE AND HEALTH CONSEQUENCES The global picture Cocaine In 2010, the regions with a
More informationANNUAL REPORT ON THE DRUG SITUATION. Portugal Commissioned by the European Monitoring Centre on Drugs and Drug Addiction
ANNUAL REPORT ON THE DRUG SITUATION Portugal - 2003 Commissioned by the European Monitoring Centre on Drugs and Drug Addiction Lisbon, October 2003 Table of Contents TABLE OF CONTENTS SUMMARY... 4 PART
More informationEpidemiology of non medical use of prescription drugs. Kamran Niaz, Survey and Statistics Section, Policy Analysis and Research Branch
Epidemiology of non medical use of prescription drugs Kamran Niaz, Survey and Statistics Section, Policy Analysis and Research Branch Monitoring of the drug use situation: Annual reports questionnaire
More informationREPORT OF THE 4 TH BIENNIAL MEETING OF CARIBBEAN NATIONAL OBSERVATORIES
REPORT OF THE 4 TH BIENNIAL MEETING OF CARIBBEAN NATIONAL OBSERVATORIES ON DRUGS SEPTEMBER 13 TO 16, 2011 Kapok Hotel Port of Spain, Trinidad and Tobago The fourth biennial meeting of Caribbean National
More informationPresent and potential perspectives for information on alcohol use in the EU
EMCDDA Present and potential perspectives for information on alcohol use in the EU Julian Vicente Luxembourg 7-8 June 2016 CNAPA meeting Topics in this presentation 1.- EMCDDA overview and its work on
More informationHorizontal Working Party on Drugs EMCDDA contribution towards a methodological framework for monitoring drugs and prison in Europe
COUNCIL OF THE EUROPEAN UNION Brussels, 15 February 2013 5420/1/13 REV 1 CORDROGUE 7 SAN 19 NOTE from: to: Subject: EMCDDA Horizontal Working Party on Drugs EMCDDA contribution towards a methodological
More informationGlobal drug trends and sustainable development
Lau Global drug trends and sustainable development Chloé Carpentier Chief, Drug Research Section UNODC Göteborg, 15 November 2017 Global trends in estimated number of drug users and people with drug user
More informationThe Scottish Burden of Disease Study, Drug use disorders technical overview
The Scottish Burden of Disease Study, 2016 Drug use disorders technical overview This resource may also be made available on request in the following formats: 0131 314 5300 nhs.healthscotland-alternativeformats@nhs.net
More information2 nd Meeting on detecting and responding to outbreaks of HIV among PWID
2 nd Meeting on detecting and responding to outbreaks of HIV among PWID Update on country situation: AUSTRIA Lisbon, 12 th October 201 Epidemiological update 2 HIV notifications in PWID Number of HIV cases
More informationDrug Trafficking and Abuse - Impediments to development - Akira Fujino United Nations Office on Drugs and Crime (UNODC)
Drug Trafficking and Abuse - Impediments to development - Akira Fujino United Nations Office on Drugs and Crime (UNODC) Shanghai, 1909 Early days 1920s-30s Century of Drug Control BACKGROUND 19th century:
More informationDrug and alcohol treatment in the North West of England 2008/09. Results from the National Drug Treatment Monitoring System (NDTMS)
Drug and alcohol treatment in the North West of England 2008/09 Results from the National Drug Treatment Monitoring System (NDTMS) Drug and alcohol treatment in the North West of England 2008/09 - Results
More informationPrepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry
Prepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry In broad terms, substance use disorders occur when a substance is used in a compulsive manner with a lack of control over
More information